FABP4 and prostate carcinoma: FABP4 can exert endocrine and exocrine effects as it is secreted from adipocytes and macrophages, and its association with prostate cancer supports further assessment of the regulatory relationships between these cells and prostate cancer progression and metastasis [49–51].